Quickly Spot Consensus Among the World's Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
242%
upside
3 price targets
|
0
%
|
|
|
|
242%
upside
3 price targets
|
0
%
|
|
|
|
236%
upside
4 price targets
|
0
%
|
|
|
29
Cullinan Oncology
CGEM
$505M
|
227%
upside
3 price targets
|
0
%
|
|
|
224%
upside
3 price targets
|
0
%
|
|
|
|
222%
upside
3 price targets
|
0
%
|
|
|
|
219%
upside
5 price targets
|
0
%
|
|
|
|
216%
upside
8 price targets
|
0
%
|
|
|
|
212%
upside
3 price targets
|
0
%
|
|
|
|
211%
upside
3 price targets
|
0
%
|
|
|
36
Rocket Pharmaceuticals
RCKT
$330M
|
206%
upside
3 price targets
|
0
%
|
|
|
205%
upside
5 price targets
|
0
%
|
|
|
|
204%
upside
3 price targets
|
0
%
|
|
|
|
199%
upside
4 price targets
|
0
%
|
|
|
|
195%
upside
4 price targets
|
0
%
|
|
|
|
194%
upside
4 price targets
|
0
%
|
|
|
|
189%
upside
4 price targets
|
0
%
|
|
|
|
183%
upside
3 price targets
|
0
%
|
|
|
|
182%
upside
7 price targets
|
0
%
|
|
|
|
181%
upside
3 price targets
|
0
%
|
|
|
|
179%
upside
4 price targets
|
0
%
|
|
|
|
179%
upside
6 price targets
|
0
%
|
|
|
|
178%
upside
3 price targets
|
0
%
|
|
|
|
177%
upside
3 price targets
|
0
%
|
|
|
|
177%
upside
5 price targets
|
0
%
|
|